Skip to main content

Theravance Bio: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Theravance Biopharma Inc. (TBPH) on Thursday reported a loss of $4.9 million in its first quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 10 cents. Earnings, adjusted for one-time gains and costs, came to 1 cent per share.

The biopharmaceutical company posted revenue of $17.7 million in the period, which did not meet Street forecasts. Four analysts surveyed by Zacks expected $17.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH

Testing Authors

Original published author was Jessica Miller. Then replaced with Abigail as the updated published author. Abigail should persist as the published author when we come back to this post.
Read Next Story